BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3086431)

  • 1. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
    Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
    J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
    Tedder TF; Clement LT; Cooper MD
    J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface antigens expressed by subsets of pre-B cells and B cells.
    McKearn JP; Baum C; Davie JM
    J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
    Hashimi L; Wang CY; Al-Katib A; Koziner B
    Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
    Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
    J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B5, a new B cell-restricted activation antigen.
    Freedman AS; Boyd AW; Anderson KC; Fisher DC; Schlossman SF; Nadler LM
    J Immunol; 1985 Apr; 134(4):2228-35. PubMed ID: 2579134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
    Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
    J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface marker expression of human B-cell lymphomas.
    Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
    AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunofluorescence analysis of the ontogeny of myeloid, T, and B lineage cells in mouse hemopoietic tissues.
    Velardi A; Cooper MD
    J Immunol; 1984 Aug; 133(2):672-7. PubMed ID: 6429241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an early activation antigen (Bac-1) on human B cells.
    Suzuki T; Sanders SK; Butler JL; Gartland GL; Komiyama K; Cooper MD
    J Immunol; 1986 Aug; 137(4):1208-13. PubMed ID: 3090143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7, a B-cell-restricted antigen that identifies preactivated B cells.
    Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
    J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
    Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
    Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice.
    McNagny KM; Cazenave PA; Cooper MD
    J Immunol; 1988 Oct; 141(8):2551-6. PubMed ID: 3262662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
    Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
    J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
    Quackenbush EJ; Letarte M
    J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes.
    Nikolova M; Guenova M; Taskov H; Marie-Cardine A; Boumsell L; Bensussan A
    Cell Immunol; 2005; 236(1-2):92-100. PubMed ID: 16197933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique antigen on mature B cells defined by a monoclonal antibody.
    Link MP; Bindl J; Meeker TC; Carswell C; Doss CA; Warnke RA; Levy R
    J Immunol; 1986 Nov; 137(9):3013-8. PubMed ID: 3489782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody.
    Tedder TF; Clement LT; Cooper MD
    J Immunol; 1985 Mar; 134(3):1539-44. PubMed ID: 3918104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant human B cells express two populations of p24 surface antigens.
    Pesando JM; Hoffman P; Conrad T
    J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
    Thorley-Lawson DA; Nadler LM; Bhan AK; Schooley RT
    J Immunol; 1985 May; 134(5):3007-12. PubMed ID: 2984280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.